Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Id buy these shares. Way oversold. Should get back to .01 from here in a few days imo.
Looks like I was right about the .0064~ bottom.
Aurora Cannabis is still undervalued, says Canaccord Genuity
The hiring of a well qualified CFO is an important development for Aurora Cannabis (TSXV:ACB), says Canaccord Genuity analyst Neil Maruoka.
This morning, Aurora announced that former QLT CFO Glen Ibbott has been appointed as the company’s chief financial officer, replacing Amy Stephenson, who had acted as Aurora’s interim CFO since last summer.
“We are delighted with the appointment of Glen, as he brings to Aurora deep experience and capabilities that match our needs as we continue to develop,” said Aurora CEO Terry Booth. “The timing is perfect as we continue executing on an aggressive growth and expansion strategy aimed at creating a global leader in the cannabis industry. We will continue to emphasize our roots as a medical cannabis company, while positioning Aurora effectively to seize the enormous opportunity we expect to be created by the legalization of adult consumer use. As we take the Aurora Standard to new heights in terms of operational, financial, governance and innovation excellence, we believe that in Glen we have found someone who ticks all these boxes, and will be a great fit for the company as we build on our leadership within the industry. Finally, I would like to thank Amy Stephenson for her significant contributions to Aurora over the past year, and for her professionalism, expertise and team spirit that made her a valued member of our team.”
Maruoka says operating an LP has become more complex than some might have first imagined, and Ibbott will be a positive for the company.
“We believe this hire fills an important role for Aurora, as Mr. Ibbott takes over from Interim CFO Amy Stephenson,” he says. “Moreover, we believe that Mr. Ibbott’s background as a Canadian Chartered Professional Accountant will be essential in interpreting the complex financial reporting for Canadian licensed producers of cannabis. Separately, the company has announced the appointment of Andrea Paine as Director of Quebec Affairs. We believe this is also a key role for the company as Aurora maintains a strong relationship with the Federal government and expands its cultivation footprint into Quebec with the acquisition of its Peloton Pharmaceuticals facility. Not unexpectedly, shares of Canadian LPs have been under pressure following the tabling of legislation to legalize recreational use of cannabis. Given the lack of macro and industry catalysts over the next few months, we continue to look for companies with differentiated strategies and potential stock-specific catalysts. As such, we remain buyers of Aurora ahead of construction milestones for its new 800,000 square foot Aurora Sky facility.”
https://www.cantechletter.com/2017/05/aurora-cannabis-still-undervalued-says-canaccord-genuity/
.0064 / .0068 would be absolute bottom imo. Hoping for a recovery after today.
Aurora has been making HUGE deals worth near a quarter billion dollars. Part of those deals is some dilution. Rest assured, this will be the largest marijuana company in the world once Aurora Sky is completed.
Aurora Announces Senior Management Change, Appoints Glen Ibbott as Chief Financial Officer
Canada NewsWire
VANCOUVER, May 8, 2017
Further Strengthens Management Team, Adding Andrea Paine as Director, Québec Affairs
TSXV: ACB
VANCOUVER, May 8, 2017 /CNW/ - Aurora Cannabis Inc. ( ACBFF
Loading...
Loading...
) (the "Company" or "Aurora") (TSXV: ACB) announced that effective today, Glen Ibbott has been appointed as Chief Financial Officer, replacing Amy Stephenson who has acted as the Company's Interim CFO since August, 2016. Mrs. Stephenson will continue to work with Aurora on a part-time basis to ensure a smooth transition. Additionally, the Company announced the appointment of Andrea Paine as its Director, Québec Affairs.
Chief Financial Officer
Glen Ibbott is a seasoned senior healthcare executive with over 20 years' experience providing financial leadership to various public entities, including management of Canadian and international capital market strategies, M&A, tax and finance, predominantly within the life sciences sector. An innovative, decisive, and insightful professional, he has excelled in delivering revenue and profitability growth, both domestically and internationally, strategy execution and shareholder value creation, including key contributions to numerous corporate transactions.
Most recently, Mr. Ibbott was CFO at QLT Inc, a NASDAQ and TSX listed Biopharmaceutical Company and played a key role in QLT's $500 million merger with Aegerion Pharmaceuticals to form Novelion Therapeutics. Prior to his time at QLT, Mr. Ibbott held various senior finance positions, including with globally operating companies such as Nordion, International Forest Products, Angiotech Pharmaceuticals, Aspreva Pharmaceuticals, and Inex Pharmaceuticals. Earlier in his career, he worked within the technology practice of KPMG.
In addition to his primary corporate responsibilities, Mr. Ibbott has held several community engagement Board positions including with the Children's Hospital of Eastern Ontario, the Community Foundation of Ottawa, and the Mulgrave Independent School Society.
Mr. Ibbott completed MBAs at Cornell University and at Queen's University, is a Canadian Chartered Professional Accountant (CPA, CA), as well as a US CPA, and holds a Bachelor's of Business Administration from Simon Fraser University.
"We are delighted with the appointment of Glen, as he brings to Aurora deep experience and capabilities that match our needs as we continue to develop," said Terry Booth, CEO. "The timing is perfect as we continue executing on an aggressive growth and expansion strategy aimed at creating a global leader in the cannabis industry. We will continue to emphasize our roots as a medical cannabis company, while positioning Aurora effectively to seize the enormous opportunity we expect to be created by the legalization of adult consumer use. As we take the Aurora Standard to new heights in terms of operational, financial, governance and innovation excellence, we believe that in Glen we have found someone who ticks all these boxes, and will be a great fit for the company as we build on our leadership within the industry. Finally, I would like to thank Amy Stephenson for her significant contributions to Aurora over the past year, and for her professionalism, expertise and team spirit that made her a valued member of our team."
"Aurora is one of the leaders and trailblazers within this remarkably fast-growing cannabis industry," added Mr. Ibbott. "I am excited about my new role and look forward to contributing and helping Aurora reach the next level in its unprecedented development. The Aurora Standard, its inclusive culture, and clear differentiation within the industry, were all important aspects that made it an easy decision to join the Company. I look forward to engaging with our partners, stakeholders, management and board of directors, in further building shareholder value and establishing Aurora as a long-term leader and success story in this sector."
Director, Québec Affairs
Additionally, the Company is pleased to report it has appointed Andrea Paine as Director, Québec Affairs, operating out of Aurora's Peloton Pharmaceuticals facility in Pointe-Claire, Québec, and in close proximity to both Montreal and Ottawa. Mrs. Paine will be responsible for external communications in Québec, including government and community relations, as well as internal communications at the Company's new Pointe-Claire facility.
A former Citizenship Judge, Paine has over twenty years of experience working for Cabinet Ministers in both the Québec Provincial and Federal Governments, including the Federal Minister of Health, whom she supported as Director of Parliamentary Affairs. In this position, she was responsible for developing new legislation, steering this through the House of Commons, as well as negotiating with Opposition parties and other stakeholder groups.
"The Aurora Standard continues to attract top talent," said Cam Battley, Executive Vice-President. "As part of our organizational DNA, we consider it extremely important to have an ongoing dialogue and a close relationship with the communities in which we operate, as well as with municipal and provincial governments. Andrea, who is fully bilingual, is extremely well connected, and has extensive government and stakeholder relations experience. Her energy, government experience, and commitment to excellence are an ideal fit for our team."
"Aurora stands out not only because of the quality of its products, customer service and innovation, but also because of its strong efforts to create meaningful connections to the political and economic environments within which it operates," added Ms. Paine. "These were all important considerations for me, and I am very excited to join the Aurora team."
Aurora Completes $75 Million Debenture Offering
VANCOUVER, May 2, 2017 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) is pleased to announce that, further to its news release dated April 11, 2017, it has completed its bought deal private placement (the "Offering") of 7.0% unsecured convertible debentures (the "Debentures") of the Company with a syndicate of investment dealers, led by Canaccord Genuity Corp., including GMP Securities L.P, Eight Capital, PI Financial Corporation, Industrial Alliance Securities Inc., and Mackie Research Capital Corporation, for gross proceeds of $75 million.
"With a cash position exceeding $160 million, we are exceptionally well positioned to execute on our expansion strategy, both nationally and internationally," said Terry Booth, CEO. "The acquisition of Peloton in Quebec and our investment in Cann Group in Australia are the first steps in growing our footprint, and we will continue to pursue aggressively other opportunities we have identified to transform Aurora from one of the largest Canadian cannabis companies into a global leader."
The Debentures are senior unsecured obligations of the Company and bear interest from the date of closing at 7.0% per annum, payable semi-annually on June 30 and December 31 of each year. The Debentures will mature on May 2, 2019 (the "Maturity Date").
The Debentures are convertible at the option of the holder into common shares of the Company at any time prior to the close of business on the Maturity Date, at a conversion price of $3.29 per common share, subject to customary anti-dilution adjustments, (the "Conversion Price"). Holders converting their Debentures will receive accrued and unpaid interest thereon, up to, but excluding, the date of conversion.
If, prior to the Maturity Date, the volume-weighted average trading price of the common shares on the TSX Venture Exchange for 10 consecutive trading days equals or exceeds $4.94, as may be adjusted from time to time, the Company may force conversion of all the then outstanding Debentures at the Conversion Price, upon giving the holders of Debenture 30 days' prior written notice.
The Company intends to use the net proceeds of the Offering for international expansion and growth opportunities.
All securities issued in connection with the Offering, which includes certain insider participation, are subject to a four month hold period expiring September 3, 2017.
An insider of the Company was issued, directly and indirectly, Debentures in the aggregate principal amount of $300,000, which constituted a "related party transaction" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The issuance to the insider is exempt from the formal valuation and the minority shareholder approval requirements of MI 61-101, as the fair market value of the Debentures issued to and the consideration paid by such person did not exceed 25% of the Company's market capitalization.
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe Claire, Quebec, near Montreal. In addition, the company is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora's common shares trade on the TSX-V under the symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC. ( ACBFF )
Terry Booth, CEO
Aurora Announces Change to Board of Directors
VANCOUVER, May 8, 2017
TSXV: ACB
VANCOUVER, May 8, 2017 /CNW/ - Aurora Cannabis Inc. (ACBFF) (the "Company" or "Aurora") (TSXV: ACB) announced today that, effective immediately, Mr. Chuck Rifici has resigned as a Director of the Company to focus on a new venture.
"We would like to thank Chuck for his valuable contributions to the development of Aurora into one of the world's largest cannabis companies, " said Michael Singer, Chairman of the Board of Directors for Aurora. "I've greatly enjoyed working with Chuck and wish him well in his new venture."
"Over my nearly two years on the Board, I was extremely impressed with how Terry and his team successfully executed on the Company's aggressive growth strategy, and transformed Aurora into a trailblazing, world-class company," said Rifici. "As a shareholder, I will continue to follow Aurora's progress with interest."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe Claire, Quebec, near Montreal. In addition, the company is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora's common shares trade on the TSX-V under the symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC. ( ACBFF )
Terry Booth, CEO
61% of sales were short today.
Try buying back in 2014 and waiting until a couple months ago like me. Granted I made money but I put some of the cash I made back in when she came tumbling down to .0006. Been holding since. Considered getting out today but I figured why not see what happens. I dont have a lot riding on this now.
Shoulda got out at .002++ like I did.
Anyone who isnt bag holding should seriously buy right now. This is about as low as shes going to get pre PR.
I am feeling Green today guys. It would be a nice move forward if she can do it. Good luck everyone!
The Q&A is what did it for me. That wreaked of bogusness.
There isnt one for the U.S. The Cannabis ETF is HMMJ and trades on the TSX.
Seen the 200$ shares the last few trading days now. Always goes away though. We need a green close today otherwise shes likely going south until the news.
Maybe. They already have a very cheap and reliable method so I doubt that.
Can someone post a chart that shows this potential spike? I personally dont see this going anywhere without good news and good volume.
Surprising that some dont see the value in a patented handheld chemical analyzer. This goes way beyond reading whats in your pot. So many people around the world have serious air and water issues and no real means to test or get their samples tested reputably. Its an expensive ordeal. I wouldn't have invested in this if it was strictly for pot even though that is cool, it wouldn't be as marketable if that were the case.
Lots going on with this company this year and going forward. I can see prices for the unit also dropping in the future. Who knows. All I know is that I believe this company is worth more than its trading for right now.
I believe in the company and the CEO who has more than enough credentials to impress me.
Odds are shes going to start trending north now. Only good news awaits. GL to all.
Holding strong with sub par volume. Hopefully we can get some EOD buys once they realize the ticker isnt moving much lower.
This is a patented product folks.
Revamping the Easy Grinder was a good move on Newgens part. They have been testing the product and learned that with fresh, sticky bud the grinder would have a hard time dispensing the product. The last thing they want is to release a sub par item when they are the first to do this. The stronger motor and modified grinder will ensure a quality grind with all kinds of bud. My only one concern with this product now would be how to clean any compacted resin from the grind wheel.
Its only a matter of time this goes back up north folks. Just my opinion and why I hold a position. Think about the long run with the product. Im personally glad they arent trying to rush an innovative product out there.
The fact that she is holding above the 10 day SMA even with the late filing news is GREAT news for the ticker. Since she hasnt continued downwards below a penny I only expect good things from here forward. Next week is going to be another hot and heavy week.
Great EOD for this ticker today. We needed to close above .0130. Profit takers and weak hands controlled the ticker yesterday and the day before (myself included). MYDX is back with the bulls IMO. I predict a close at or around the .016-.0175~ mark tomorrow with similar volume and action.
Need a .0130+ close or higher today, or shes going lower without news. IMO.
The only thing bringing this back up is something concrete like a plane built (at least the prototype that is now past due) or something on paper showing these multi million dollar deals. Come on guys be realistic here. None of these fluff PR's are going to get this stock going anywhere.
Shes going to be trading at a penny+ once product starts rolling out and they show revenues. Definitely a longer term play here.
People are nuts not to sell when they are up. I have flipped this baby 3 times now while keeping a good core position. Even if it dropped to 0001 I have already made way more than i could ever lose with this. Thats how people need to treat pennys.
PMEA has been offered 12 mil for EVADA
.0003 is bottom. Plenty of people holding there. We just need some concrete news otherwise she isnt going anywhere.
Absolutely need to close at or above .0029. Looking good so far. .0029 is the last support level. Could drop a lot if we dont get a decent close today.
Also a CEO shouldnt have to continually talk about transparency. A CEO shouldnt need to remind shareholders that he/she is going to do the right thing...
33 pre ordered planes.. I am guessing no money was put down on these since this company isnt even close to being able to build a complete, running plane. Who would pre order 33 planes from a company that isnt even close to being able to build them? I hate to sound so negative but the facts are the facts and thats why the PPS is dropping. I would love to see these cash deals and agreements on PAPER and not some fluff PR. So far, in reality, NOTHING has really happened or been proven yet. Not to mention the whole DiNelly thing just screams red flag.
Im just saying.. You dont know when a bounce is coming. So its really a useless thing to post on here. If you know how to read charts and you see something, than post it. Other than that its just wishful thinking and possibly getting people to buy at bad levels.
I wish youd relax with your "big bounce coming" posts. The stock has been crashing since you started with that.
I sold back right after it broke .002 because I was holding 0002's for two years. Today this company is not what it was when I originally bought into it. Im just waiting for a true bottom before i re enter which I believe is 0003. I sold because the charts indicated this exact decline. Is PMEA legit? Possibly. However I think its going to be close to 6-12 months before we start seeing some real stuff going.
Are you guys really loading up all these shares you say you are? Because I highly doubt it.
I slammed that .0037 ask heavy. Others must have too. For a moment I felt like I popped the stock up myself lol!
Shes about to hit the 10 day sma. We shall see what happens.